3G8I PDB NFT

Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeidj4prj4suhdjaqhp2j4vbyopyjavcckcmrq2omnjdix3vc26joey/metadata.json

IPFS of structure file:

bafybeibtpv2i2idb4tczfs7ytgkhhm5xea5bdofq6turx56bpml732gtq4/3g8i.pdb

MOLNFT 3G8I research and analysis (ICN3D with VR)

FASTA sequences

>3g8i_A mol:protein length:270 Peroxisome proliferator-activated receptor alpha
ETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY
>3g8i_Z mol:protein length:13 Nuclear receptor coactivator 1
KDHQLLRYLLDKD

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 3G8I
TITLE: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
DOI: 10.1016/j.bmcl.2009.03.036
AUTHORS: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer, M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.
ACCESSION DATE: 02/12/09
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/3G8I